Cargando…
Antihypertensive medication and outcome in patients with COVID-19 compared to non-COVID respiratory infections
BACKGROUND: Recent reports suggested no adverse effects of antihypertensive medication including inhibitors of the renin-angiotensin system on outcome of patients with coronavirus disease 19 (COVID-19). However, most of these studies lack adequate control groups, and regional and socio-economic diff...
Autores principales: | Blum, S, Lampart, M, Zhou, Q, Mueller, C, Osswald, S, Kuster, G M, Twerenbold, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767616/ http://dx.doi.org/10.1093/eurheartj/ehab724.2395 |
Ejemplares similares
-
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study
por: Lampart, Maurin, et al.
Publicado: (2022) -
Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
por: Vischer, Annina S., et al.
Publicado: (2021) -
Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection
por: Simon, Noemi R., et al.
Publicado: (2021) -
Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study
por: Atila, Cihan, et al.
Publicado: (2022) -
Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study
por: Bruni, Flavio, et al.
Publicado: (2022)